The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $58.64

Today's change-0.65 -1.10%
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.
 

LifePoint Health Inc

Nasdaq: LPNT
Last

(U.S.) $58.64

Today's change-0.65 -1.10%
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.

LifePoint Health Inc crosses below 50-day moving average

LifePoint Health Inc closed lower Friday, dropping (U.S.)$0.65 or 1.10% to (U.S.)$58.64 and crossing below its 50-day moving average. Over the last five days, shares have gained 2.16%, but are down 20.11% for the last year to date. Shares have underperformed the S&P 500 by 36.76% during the last year.

Key company metrics

  • Open(U.S.) $59.03
  • Previous close(U.S.) $59.29
  • High(U.S.) $59.72
  • Low(U.S.) $58.30
  • Bid / Ask-- / --
  • YTD % change-20.11%
  • Volume330,343
  • Average volume (10-day)401,376
  • Average volume (1-month)446,631
  • Average volume (3-month)449,613
  • 52-week range(U.S.) $54.82 to (U.S.) $78.45
  • Beta0.89
  • Trailing P/E19.72×
  • P/E 1 year forward16.70×
  • Forward PEG2.43×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.97
Updated September 23 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.48%

Based on its net profit margin of 2.48%, LifePoint Health Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.67%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue1,5921,5811,3711,310
Total other revenue--------
Total revenue1,5921,5811,3711,310
Gross profit563553500478
Total cost of revenue1,0291,028871832
Total operating expense1,5621,5441,2881,237
Selling / general / administrative346356286274
Research & development--------
Depreciation / amortization85867270
Interest expense (income), net operating--------
Unusual expense (income)22102
Other operating expenses, total41353031
Operating income30378372
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax30378772
Income after tax20245546
Income tax, total10133126
Net income17225344
Total adjustments to net income--------
Net income before extra. items17225344
Minority interest-3-2-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items17225344
Inc. avail. to common incl. extra. items17225344
Diluted net income17225344
Dilution adjustment--------
Diluted weighted average shares44454646
Diluted EPS excluding extraordinary itemsvalue per share0.380.491.160.94
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.710.501.160.97